Join us for our session “Ask the Experts: Preclinical Immunogenicity Risk Assessment Tools and Mitigation” with Annie De Groot, Ph.D. (EpiVax), Sofie Denies, Ph.D. (SD Analytics), Laurent Malherbe Ph.D., (Eli Lilly and Company), @Brian Roberts, Ph.D. (EpiVax), and Sofie Pattijn (ImmunXperts) on 4/30 from 12pm-1pm ET. This will be a live 1-hour discussion thread in the AAPS Community. Our panelists will be available in the AAPS Community to answer questions around particular assays or methods, how to tackle novel modalities, what data to report in the immunogenicity risk assessment report, and more.
Do you have questions about how immunogenicity risk of biotherapeutics needs to be taken into account when selecting a leads candidate for human testing? This is the time to ask anything!
No need to register; just add this event to your calendar as a reminder.
Click the AAPS COMMUNITY to join the AMA session! This discussion will be pinned to the top left corner of the site and it will be the first thing you see!